Moderna MRNA shares suffered a sharp reversal on Friday, falling close to 10% after a strong October rally had pushed the biotechnology to its 52-week high. The shares, which reached $242.29 during their recent advance, were trading near $213 at the time of writing.
Read on invezz.com